Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Focused Shockwave (ESWT), Radial Pressure Waves (EPAT), And Electromagnetic Transduction Therapy (EMTT) For Lower Extremity Musculoskeletal Injuries

NCT: NCT07526753 · ACTIVE_NOT_RECRUITING

NCT IDNCT07526753
StatusACTIVE_NOT_RECRUITING
Start Date2026-03-15
Completion2035-04

Brief Summary

The purpose of this study is to assess the efficacy of ESWT, EPAT, EMTT and the combination of these therapies in treating patients with lower extremity soft tissue, cartilage, and bone injuries.

Frequently Asked Questions

What is Focused Shockwave (ESWT), Radial Pressure Waves (EPAT), And Electromagnetic Transduction Therapy (EMTT) For Lower Extremity Musculoskeletal Injuries?

Focused Shockwave (ESWT), Radial Pressure Waves (EPAT), And Electromagnetic Transduction Therapy (EMTT) For Lower Extremity Musculoskeletal Injuries is a clinical trial registered under NCT07526753. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07526753?

The current status of NCT07526753 (Focused Shockwave (ESWT), Radial Pressure Waves (EPAT), And Electromagnetic Transduction Therapy (EMTT) For Lower Extremity Musculoskeletal Injuries) is: ACTIVE_NOT_RECRUITING.

When did Focused Shockwave (ESWT), Radial Pressure Waves (EPAT), And Electromagnetic Transduction Therapy (EMTT) For Lower Extremity Musculoskeletal Injuries start?

Focused Shockwave (ESWT), Radial Pressure Waves (EPAT), And Electromagnetic Transduction Therapy (EMTT) For Lower Extremity Musculoskeletal Injuries started on 2026-03-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑